Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

NCT07072221

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET

NCT07070648

Conditions: DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL

NCT06682130

Conditions: Diffuse Large B-cell Lymphoma(DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

NCT06976437

Conditions: B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Recruiting

CBT and the Neural Circuits of Anxiety

NCT05549102

Conditions: Anxiety, Anxiety Depression, Anxiety Disorder Generalized, +18 more
Locations: Institute of Cognitive Neuroscience, University College London London, United Kingdom

View Trial Details

Recruiting

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

NCT07009002

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

NCT06785324

Conditions: B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL, Burkitt Lymphoma, +17 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

NCT07001540

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT06550427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial

NCT06700798

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions